See more : Afentra plc (AET.L) Income Statement Analysis – Financial Results
Complete financial analysis of Kindly MD, Inc. (KDLY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kindly MD, Inc., a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- Kohinoor Foods Limited (KOHINOOR.NS) Income Statement Analysis – Financial Results
- World Houseware (Holdings) Limited (0713.HK) Income Statement Analysis – Financial Results
- Aichi Tokei Denki Co., Ltd. (7723.T) Income Statement Analysis – Financial Results
- Neovasc Inc. (NVCN.TO) Income Statement Analysis – Financial Results
- Medibank Private Limited (MDBPF) Income Statement Analysis – Financial Results
Kindly MD, Inc. (KDLY)
About Kindly MD, Inc.
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 3.77M | 3.79M | 2.50M |
| Cost of Revenue | 3.93M | 4.38M | 1.59M |
| Gross Profit | -158.54K | -595.30K | 914.92K |
| Gross Profit Ratio | -4.21% | -15.72% | 36.53% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.36M | 6.27M | 2.36M |
| Selling & Marketing | 0.00 | -4.18M | -1.50M |
| SG&A | 1.36M | 2.10M | 853.58K |
| Other Expenses | 105.64K | 152.82K | 88.00K |
| Operating Expenses | 1.36M | 2.10M | 853.58K |
| Cost & Expenses | 5.39M | 6.48M | 2.44M |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 55.84K | 0.00 | 0.00 |
| Depreciation & Amortization | 203.22K | 122.01K | 63.40K |
| EBITDA | -1.36M | -2.42M | 66.20K |
| EBITDA Ratio | -36.05% | -67.90% | 4.98% |
| Operating Income | -1.62M | -2.69M | 61.34K |
| Operating Income Ratio | -42.99% | -71.12% | 2.45% |
| Total Other Income/Expenses | 2.76K | 152.82K | 88.00K |
| Income Before Tax | -1.62M | -2.54M | 149.34K |
| Income Before Tax Ratio | -42.92% | -67.09% | 5.96% |
| Income Tax Expense | 0.00 | 5.00 | 3.00 |
| Net Income | -1.62M | -2.54M | 149.34K |
| Net Income Ratio | -42.92% | -67.09% | 5.96% |
| EPS | -0.27 | -0.43 | 0.03 |
| EPS Diluted | -0.27 | -0.43 | 0.03 |
| Weighted Avg Shares Out | 5.97M | 5.97M | 5.97M |
| Weighted Avg Shares Out (Dil) | 5.97M | 5.97M | 5.97M |
KindlyMD(TM) Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah
KindlyMD Becomes First Utah Alternative Medical Treatment Company to Contract Under State's Top Insurance Payors
KindlyMD to Present at the KCSA Cannabis Virtual Investor Conference on June 5th
WallachBeth Announces Closing of KindlyMD's $6.8m IPO
KindlyMD Announces Closing of $6.8 Million Initial Public Offering
WallachBeth Capital Announces Pricing of KindlyMD's $6.8 Million IPO
KindlyMD Announces Pricing of $6.8 Million Initial Public Offering
Source: https://incomestatements.info
Category: Stock Reports